Mechanism of long non-coding RNA GHET1 in tumors of the digestive system

doi:10.3760/cma.j.cn371439-20200209-00024

Abstract

Abstract:

Gastric cancer highly expressed transcript 1 (GHET1) is first found in gastric cancer and is a long non-coding RNA (lncRNA). GHET1 is located on chromosome 7q36.1, and is highly expressed in many tumors. High expression of GHET1 is closely related to poor prognosis. Studies have found that GHET1 is involved in regulating many physiological and pathological processes of the body through interaction with microRNAs (miRNAs) or proteins, especially in digestive system tumors, and is expected to become a valuable tumor marker and therapeutic target in the future.

Key words: RNA,long noncoding, Digestive system neoplasms, Gastric cancer highly expressed transcript 1

Ma Yingji, Sun Libin, Qiu Wensheng. Mechanism of long non-coding RNA GHET1 in tumors of the digestive system[J]. Journal of International Oncology, 2020, 47(5): 304-307.

References 33

[1]	Espinosa JM. On the origin of lncRNAs: missing link found[J]. Trends Genet, 2017,33(10):660-662. DOI: 10.1016/j.tig.2017.07.005. doi: 10.1016/j.tig.2017.07.005 pmid: 28778681
[2]	Jandura A, Krause HM. The new RNA world: growing evidence for long noncoding RNA functionality[J]. Trends Genet, 2017,33(10):665-676. DOI: 10.1016/j.tig.2017.08.002. doi: 10.1016/j.tig.2017.08.002 pmid: 28870653
[3]	Tian X, Xu G. Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis[J]. BMJ Open, 2015,5(9):e008653. DOI: 10.1136/bmjopen-2015-008653. doi: 10.1136/bmjopen-2015-008653 pmid: 26423854
[4]	Yu L, Chen S, Bao H, et al. The role of lncRNA CASC2 on prognosis of malignant tumors: a meta-analysis and bioinformatics[J]. Onco Targets Ther, 2018,11:4355-4365. DOI: 10.2147/OTT.S166132. doi: 10.2147/OTT.S166132 pmid: 30100741
[5]	Yang F, Xue X, Zheng L, et al. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability[J]. FEBS J, 2014,281(3):802-813. DOI: 10.1111/febs.12625. doi: 10.1111/febs.12625
[6]	Song J, Chen X, Tian Q, et al. The value of lncRNA GHET1 as a prognostic factor for survival of chinese cancer outcome: a meta-analysis[J]. Dis Markers, 2019,2019:5824190. DOI: 10.1155/2019/5824190. doi: 10.1155/2019/5824190 pmid: 31885739
[7]	Ye J, Sun H, Feng Z, et al. Prognostic significance of lncRNA GHET1 expression in various cancers: a systematic review and meta-analysis[J]. Biosci Rep, 2019,39(10). pii: BSR20190608. DOI: 10.1042/BSR20190608.
[8]	Li C, Chen J, Zhang K, et al. Progress and prospects of long nonco-ding RNAs (lncRNAs) in hepatocellular carcinoma[J]. Cell Physiol Biochem, 2015,36(2):423-434. DOI: 10.1159/000430109. doi: 10.1159/000430109 pmid: 25968300
[9]	蒋志俊, 陈洁, 黎乐群. 长链非编码RNA在肝癌侵袭转移中的研究进展[J]. 医学研究生学报, 2019,32(7):765-770. DOI: 10.16571/j.cnki.1008-8199.2019.07.019.
[10]	Ding G, Li W, Liu J, et al. LncRNA GHET1 activated by H3K27 acetylation promotes cell tumorigenesis through regulating ATF1 in hepatocellular carcinoma[J]. Biomed Pharmacother, 2017,94:326-331. DOI: 10.1016/j.biopha.2017.07.046. doi: 10.1016/j.biopha.2017.07.046 pmid: 28772210
[11]	Wang Z, Luo S, Wan Z, et al. Glabridin arrests cell cycle and inhibits proliferation of hepatocellular carcinoma by suppressing braf/MEK signaling pathway[J]. Tumour Biol, 2016,37(5):5837-5846. DOI: 10.1007/s13277-015-4177-5. doi: 10.1007/s13277-015-4177-5 pmid: 26586395
[12]	Jin L, He Y, Tang S, et al. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2[J]. J Cell Physiol, 2018,233(6):4726-4734. DOI: 10.1002/jcp.26257. doi: 10.1002/jcp.26257 pmid: 29139562
[13]	邹磊, 颉晚林, 张鑫, 等. LncRNA在胃癌早期诊断中的研究进展[J]. 国际检验医学杂志, 2019,40(1):102-107. DOI: 10.3969/j.issn.1673-4130.2019.01.027.
[14]	Lemm I, Ross J. Regulation of c-MYC mRNA decay by translational pausing in a coding region instability determinant[J]. Mol Cell Biol, 2002,22(12):3959-3969. DOI: 10.1128/MCB.22.12.3959-3969.2002. doi: 10.1128/mcb.22.12.3959-3969.2002 pmid: 12024010
[15]	杜清, 杨巧红, 张新江, 等. c-myc在胃癌治疗方面的研究进展[J]. 转化医学电子杂志, 2018,5(9):53-58. DOI: 10.12095/j.issn.2095-6894.2018.09.011.
[16]	Xia Y, Yan Z, Wan Y, et al. Knockdown of long noncoding RNA GHET1 inhibits cell-cycle progression and invasion of gastric cancer cells[J]. Mol Med Rep, 2018,18(3):3375-3381. DOI: 10.3892/mmr.2018.9332. doi: 10.3892/mmr.2018.9332 pmid: 30066922
[17]	Massague J. G₁ cell-cycle control and cancer[J]. Nature, 2004,432(7015):298-306. DOI: 10.1038/nature03094. doi: 10.1038/nature03094 pmid: 15549091
[18]	Tsihlias J, Kapusta L, Slingerland J. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer[J]. Annu Rev Med, 1999,50(1):401-423. DOI: 10.1146/annurev.med.50.1.401. doi: 10.1146/annurev.med.50.1.401
[19]	Donjerkovic D, Scott DW. Regulation of the G₁ phase of the mammalian cell cycle[J]. Cell Res, 2000,10(1):1-16. DOI: 10.1038/sj.cr.7290031. doi: 10.1038/sj.cr.7290031 pmid: 10765979
[20]	Zhang X, Bo P, Liu L, et al. Overexpression of long non-coding RNA GHET1 promotes the development of multidrug resistance in gastric cancer cells[J]. Biomed Pharmacother, 2017,92:580-585. DOI: 10.1016/j.biopha.2017.04.111. doi: 10.1016/j.biopha.2017.04.111 pmid: 28578256
[21]	Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017[J]. CA Cancer J Clin, 2017,67(3):177-193. DOI: 10.3322/caac.21395. doi: 10.3322/caac.21395 pmid: 28248415
[22]	Tang X, Qiao X, Chen C, et al. Regulation mechanism of long noncoding RNAs in colon cancer development and progression[J]. Yonsei Med J, 2019,60(4):319-325. DOI: 10.3349/ymj.2019.60.4.319. doi: 10.3349/ymj.2019.60.4.319 pmid: 30900417
[23]	利基林. 长链非编码RNA在结直肠癌中的研究进展[J]. 微创医学, 2018,13(6):766-768. DOI: 10.11864/j.issn.1673.2018.06.19.
[24]	Zhou J, Li X, Wu M, et al. Knockdown of long noncoding RNA GHET1 inhibits cell proliferation and invasion of colorectal cancer[J]. Oncol Res, 2016,23(6):303-309. DOI: 10.3727/096504016X14567549091305. doi: 10.3727/096504016X14567549091305 pmid: 27131316
[25]	Findlay VJ, Wang C, Watson DK, et al. Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer[J]. Cancer Gene Ther, 2014,21(5):181-187. DOI: 10.1038/cgt.2014.15. doi: 10.1038/cgt.2014.15
[26]	Lim SH, Becker TM, Chua W, et al. Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer[J]. J Clin Pathol, 2014,67(10):848-853. DOI: 10.1136/jclinpath-2014-202499. doi: 10.1136/jclinpath-2014-202499
[27]	Kim K, Jutooru I, Chadalapaka G, et al. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer[J]. Oncogene, 2013,32(13):1616-1625. DOI: 10.1038/onc.2012.193. doi: 10.1038/onc.2012.193
[28]	Zhou HY, Zhu H, Wu XY, et al. Expression and clinical significance of long-non-coding RNA GHET1 in pancreatic cancer[J]. Eur Rev Med Pharmacol Sci, 2017,21(22):5081-5088. DOI: 10.26355/eurrev_201711_13822. doi: 10.26355/eurrev_201711_13822 pmid: 29228419
[29]	Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016,66(2):115-132. DOI: 10.3322/caac.21338. doi: 10.3322/caac.21338 pmid: 26808342
[30]	李晓敏, 邢瑶, 查文娟, 等. 长链非编码RNA在食管癌中作用的研究进展[J]. 山东医药, 2019,59(19):94-97. DOI: 10.396/j.issn.1002-266X.2019.19.027.
[31]	Liu H, Zhen Q, Fan Y. LncRNA GHET1 promotes esophageal squamous cell carcinoma cells proliferation and invasion via induction of EMT[J]. Int J Biol Markers, 2017,32(4):e403-e408. DOI: 10.5301/ijbm.5000304. doi: 10.5301/ijbm.5000304 pmid: 28983895
[32]	Sasaki K, Natsugoe S, Ishigami S, et al. Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma[J]. J Exp Clin Cancer Res, 2009,28:158. DOI: 10.1186/1756-9966-28-158. doi: 10.1186/1756-9966-28-158 pmid: 20025748
[33]	王国田, 张洋洋, 王志敏, 等. 上皮-间质转化在食管癌侵袭转移中的研究进展[J]. 医学综述, 2014,20(23):4280-4283. DOI: 10.3969/j.issn.1006-2084.014.23.022.